Icon

UNASYN (nda050608)- (EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL,EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL,EQ 500MG BASE/VIAL;EQ 250MG BASE/VIAL,EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL)

AMPICILLIN SODIUM; SULBACTAM SODIUM PFIZER
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL,EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL,EQ 500MG BASE/VIAL;EQ 250MG BASE/VIAL,EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL
No No
Expired Expired
None None
None No
UNASYN is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. *Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli, Klebsiella spp. (including K. pneumoniae), Proteus mirabilis, Bacteroides fragilis, Enterobacter spp., and Acinetobacter calcoaceticus. *Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. pneumoniae), Bacteroides spp. (including B. fragilis), and Enterobacter spp. *Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis).
20 0 15
Total Other Developers 1
Drugs with Suitability No
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL ** ** - - -
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL ** ** - - -
EQ 500MG BASE/VIAL;EQ 250MG BASE/VIAL ** ** - - -
EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 12
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** *** *** *** ******** ********** ******** ******** ********* *********** *** ********** *, *******, ****** *****, ***** (***) ***
****** *** ****** ***** *.*.*. *********** *** **** ******** ********** **, *******, *****, ***** (***) ***
****** ***** ****** ******* ********* ****** ******* *********** ****-***, **.**.***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ***** ****** ******* ******** ****** ******* ******* *** *********** ****-*, **** **. **-**,**-**,**,**,***,*** *.*.*., ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** ******* ***** *** ******* ******* *********** ** **: *** ** ***, *** ** ***, *** ** ***, *** ** ***, *****, ***, **** **: *-*/*, *-* & *-*, ********* *******, ********* ******, ************, ********* ******, ***** (***) ***
****** ***** ****** ******* ******** ****** ******* ******* *** *********** ****-*, **** **. **-**,**-**,**,**,***,*** *.*.*., ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** ******* ********* ****** ******* *********** ****-***, **.**.***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ****** ****** ********* ******* ******* *********** ***, *.*.*.*., *********, ********, ******* ******, ***** (***) ***
****** ************ ***** ************ ******* *********** (***), **** **. ***-*, *********** ****** **** ****, ********** ****, ****** *****, *********, ********* ******, ***** (***) ***
****** ************ ************ *********** ******* ******* *********** **** ****** ********, ***/* & ***/**, *************, ***********, ************ ****,, *********, ********* ******, ***** (***) ***
****** *********** *********** ** *********** * ***** ******* ******, ****, **** ******, ******* (***) ***
****** ******** *** *** *** ******** ********** ******** ******** ********* *********** *** ********** *, *******, ****** *****, ***** (***) ***
****** *** ****** ***** *.*.*. *********** *** **** ******** ********** **, *******, *****, ***** (***) ***
****** ***** ****** ******* ***** *** ******* ******* *********** ** **: *** ** ***, *** ** ***, *** ** ***, *** ** ***, *****, ***, **** **: *-*/*, *-* & *-*, ********* *******, ********* ******, ************, ********* ******, ***** (***) ***
****** ***** ****** ******* ******** ****** ******* ******* *** *********** ****-*, **** **. **-**,**-**,**,**,***,*** *.*.*., ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** ******* ********* ****** ******* *********** ****-***, **.**.***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ****** ****** ********* ******* ******* *********** ***, *.*.*.*., *********, ********, ******* ******, ***** (***) ***
****** ************ ***** *.*.*. *********** *** **** ******** ********** **, *******, *****, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.